• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白激酶PKR的表达受IRF-1调控,且在5q-相关白血病中降低。

Expression of the protein kinase PKR in modulated by IRF-1 and is reduced in 5q- associated leukemias.

作者信息

Beretta L, Gabbay M, Berger R, Hanash S M, Sonenberg N

机构信息

Department of Biochemistry, McGill University, Montréal, Québec, Canada.

出版信息

Oncogene. 1996 Apr 4;12(7):1593-6.

PMID:8622878
Abstract

The transcription factor IRF-1 (interferon regulatory factor 1) is an activator of type I interferon and interferon-inducible genes. IRF-1 manifests tumor suppressor activity. Its overexpression results in inhibition of cell growth, and deletions of the IRF-1 gene were demonstrated in a number of human leukemias and myelodysplasias. Although the mechanism by which IRF-1 affects cell growth is unknown, it is believed that IRF-1 activates a set of genes that negatively regulate cell growth. The double-stranded RNA-dependent protein kinase (PKR), which is an interferon-inducible gene, contains a promoter element for the binding of IRF-1 and exhibits antiproliferative properties. Consequently, we investigated the role of IRF-1 in PKR expression. Here, we show that in IRF-1-deficient embryonic fibroblasts, PKR expression is reduced relative to wild-type cells. This result predicts diminished expression of PKR as a potential consequence of deletion of the IRF-1 gene in human leukemias. We show that cells of the human leukemic U937 cell line contain a deletion of one IRF-1 gene and express low levels of PKR. We demonstrate that upregulation of IRF-1 expression in U937 cells by transfection is sufficient to induce PKR expression. We also found a marked reduction in the expression of PKR in blood samples from two patients with myelodysplasias, carrying a deletion of chromosome 5q, a locus to which IRF-1 was mapped. These results show that IRF-1 activates PKR expression and suggest that loss of one allele of the IRF-1 gene is sufficient to affect PKR expression. Therefore, PKR is a strong candidate for a mediator of the tumor suppressor activity of IRF-1.

摘要

转录因子IRF-1(干扰素调节因子1)是I型干扰素和干扰素诱导基因的激活剂。IRF-1具有肿瘤抑制活性。其过表达会导致细胞生长受到抑制,并且在许多人类白血病和骨髓发育异常中都证实了IRF-1基因的缺失。尽管IRF-1影响细胞生长的机制尚不清楚,但据信IRF-1会激活一组对细胞生长起负调节作用的基因。双链RNA依赖性蛋白激酶(PKR)是一种干扰素诱导基因,它含有一个用于IRF-1结合的启动子元件,并具有抗增殖特性。因此,我们研究了IRF-1在PKR表达中的作用。在此,我们表明,在IRF-1缺陷的胚胎成纤维细胞中,与野生型细胞相比,PKR表达降低。这一结果预示着,在人类白血病中,IRF-1基因缺失可能会导致PKR表达减少。我们发现人类白血病U937细胞系的细胞中一个IRF-1基因缺失,且PKR表达水平较低。我们证明,通过转染上调U937细胞中IRF-1的表达足以诱导PKR表达。我们还发现,两名患有骨髓发育异常且5号染色体q臂缺失(IRF-1基因定位于该位点)的患者的血液样本中,PKR的表达显著降低。这些结果表明,IRF-1激活PKR表达,并提示IRF-1基因一个等位基因的缺失就足以影响PKR表达。因此,PKR是IRF-1肿瘤抑制活性介导因子的有力候选者。

相似文献

1
Expression of the protein kinase PKR in modulated by IRF-1 and is reduced in 5q- associated leukemias.蛋白激酶PKR的表达受IRF-1调控,且在5q-相关白血病中降低。
Oncogene. 1996 Apr 4;12(7):1593-6.
2
IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR.IRF-1诱导的细胞生长抑制和干扰素诱导需要蛋白激酶PKR的活性。
Oncogene. 1995 Aug 3;11(3):439-45.
3
Activation of multiple growth regulatory genes following inducible expression of IRF-1 or IRF/RelA fusion proteins.IRF-1或IRF/RelA融合蛋白诱导表达后多个生长调节基因的激活。
Oncogene. 1997 Sep 18;15(12):1425-35. doi: 10.1038/sj.onc.1201318.
4
Interferon-gamma regulation of the human mimecan promoter.人 mimecan 启动子的干扰素-γ 调控
Mol Vis. 2003 Jun 30;9:277-87.
5
Isolation of the interferon-inducible RNA-dependent protein kinase Pkr promoter and identification of a novel DNA element within the 5'-flanking region of human and mouse Pkr genes.干扰素诱导的RNA依赖性蛋白激酶Pkr启动子的分离以及人和小鼠Pkr基因5'侧翼区域内一个新的DNA元件的鉴定。
Virology. 1997 Jan 6;227(1):119-30. doi: 10.1006/viro.1996.8306.
6
Role of double-stranded RNA-activated protein kinase in human hematological malignancies.双链RNA激活蛋白激酶在人类血液系统恶性肿瘤中的作用
Cancer Res. 1997 Mar 1;57(5):943-7.
7
The genes of interferons and interferon-related factors: localization and relationships with chromosome aberrations in cancer.干扰素及干扰素相关因子的基因:定位及其与癌症中染色体畸变的关系
Arch Immunol Ther Exp (Warsz). 2000;48(2):95-100.
8
A dominant negative mutant of an IFN regulatory factor family protein inhibits both type I and type II IFN-stimulated gene expression and antiproliferative activity of IFNs.干扰素调节因子家族蛋白的显性负性突变体可抑制I型和II型干扰素刺激的基因表达以及干扰素的抗增殖活性。
J Immunol. 1996 Dec 1;157(11):5145-54.
9
Negative modulation of alpha1(I) procollagen gene expression in human skin fibroblasts: transcriptional inhibition by interferon-gamma.人皮肤成纤维细胞中α1(I)前胶原基因表达的负调控:γ干扰素对转录的抑制作用
J Cell Physiol. 1999 Apr;179(1):97-108. doi: 10.1002/(SICI)1097-4652(199904)179:1<97::AID-JCP12>3.0.CO;2-E.
10
Identification of the lysyl oxidase gene as target of the antioncogenic transcription factor, IRF-1, and its possible role in tumor suppression.赖氨酰氧化酶基因作为抗癌转录因子IRF-1的靶点的鉴定及其在肿瘤抑制中的可能作用。
Cancer Res. 1996 May 15;56(10):2417-21.

引用本文的文献

1
Protein kinase R regulates pancreatic ductal adenocarcinoma progression by modulating the cell cycle via GADD45A.蛋白激酶R通过GADD45A调节细胞周期来调控胰腺导管腺癌的进展。
Sci Rep. 2025 Jul 10;15(1):24966. doi: 10.1038/s41598-025-06213-4.
2
Protein kinase RNA-activated controls mitotic progression and determines paclitaxel chemosensitivity through B-cell lymphoma 2 in ovarian cancer.蛋白激酶 RNA 激活物通过 B 细胞淋巴瘤 2 控制有丝分裂进程,并决定卵巢癌对紫杉醇的化疗敏感性。
Oncogene. 2021 Dec;40(50):6772-6785. doi: 10.1038/s41388-021-02117-5. Epub 2021 Nov 19.
3
PKR: A Kinase to Remember.
PKR:一个值得铭记的激酶。
Front Mol Neurosci. 2019 Jan 9;11:480. doi: 10.3389/fnmol.2018.00480. eCollection 2018.
4
Interferon regulatory factor 1 inactivation in human cancer.干扰素调节因子 1 在人类癌症中的失活。
Biosci Rep. 2018 May 8;38(3). doi: 10.1042/BSR20171672. Print 2018 Jun 29.
5
Roles of protein kinase R in cancer: Potential as a therapeutic target.蛋白激酶R在癌症中的作用:作为治疗靶点的潜力。
Cancer Sci. 2018 Apr;109(4):919-925. doi: 10.1111/cas.13551. Epub 2018 Mar 23.
6
PKR negatively regulates leukemia progression in association with PP2A activation, Bcl-2 inhibition and increased apoptosis.PKR 负向调控白血病进展,与 PP2A 激活、Bcl-2 抑制和凋亡增加有关。
Blood Cancer J. 2013 Sep 6;3(9):e144. doi: 10.1038/bcj.2013.42.
7
Prognostic significance of combinations of RNA-dependent protein kinase and EphA2 biomarkers for NSCLC.RNA 依赖的蛋白激酶和 EphA2 生物标志物联合对 NSCLC 的预后意义。
J Thorac Oncol. 2013 Mar;8(3):301-8. doi: 10.1097/JTO.0b013e318282def7.
8
Interferon-γ upregulates expression of IFP35 gene in HeLa cells via interferon regulatory factor-1.干扰素-γ 通过干扰素调节因子-1 上调 HeLa 细胞中 IFP35 基因的表达。
PLoS One. 2012;7(12):e50932. doi: 10.1371/journal.pone.0050932. Epub 2012 Dec 4.
9
Increased expression of the dsRNA-activated protein kinase PKR in breast cancer promotes sensitivity to doxorubicin.dsRNA 激活蛋白激酶 PKR 在乳腺癌中的表达增加可提高对阿霉素的敏感性。
PLoS One. 2012;7(9):e46040. doi: 10.1371/journal.pone.0046040. Epub 2012 Sep 24.
10
Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma.nc886,一种非编码 RNA,在胆管癌细胞蛋白激酶 R 通路中发挥细胞死亡/增殖作用。
Oncogene. 2013 Aug 8;32(32):3722-31. doi: 10.1038/onc.2012.382. Epub 2012 Aug 27.